21 CFR 866.6030 - AFP-L3% immunological test system.

Code of Federal Regulations - Title 21: Food and Drugs

Linked as:

Text




 

Title 21: Food and Drugs

CHAPTER I: FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED)

SUBCHAPTER H: MEDICAL DEVICES

PART 866: IMMUNOLOGY AND MICROBIOLOGY DEVICES

Subpart G: Tumor Associated Antigen immunological Test Systems

866.6030 - AFP-L3% immunological test system.

(a) Identification. An AFP-L3% immunological test system is an in vitro device that consists of reagents and an automated instrument used to quantitatively measure, by immunochemical techniques, AFP and AFP-L3 subfraction in human serum. The device is intended for in vitro diagnostic use as an aid in the risk assessment of patients with chronic liver disease for development of hepatocellular carcinoma, in conjunction with other laboratory findings, imaging studies, and clinical assessment.

(b) Classification. Class II (special controls). The special control is FDA's guidance document entitled ?Class II Special Controls Guidance Document: AFP-L3% Immunological Test Systems.? See ? 866.1(e) for the availability of this guidance document.

[70 FR 57749, Oct. 4, 2005]



Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company